Results 111 to 120 of about 12,045 (194)

P-1878. Intravenous Ganciclovir Administration Outcomes via an Outpatient Parenteral Antimicrobial Therapy (OPAT) Program

open access: yesOpen Forum Infectious Diseases
Background Intravenous (IV) ganciclovir is used in the management of herpesvirus infections including cytomegalovirus (CMV). Ganciclovir is usually administered in the inpatient setting given the need for close monitoring of hematologic and renal ...
Dhruv Patel   +4 more
semanticscholar   +1 more source

Patient Characteristics and Outcomes of Outpatient Parenteral Antimicrobial Therapy: A Retrospective Study

open access: yesCanadian Journal of Infectious Diseases and Medical Microbiology, 2016
Outpatient parenteral antimicrobial therapy (OPAT) is a safe and effective alternative to hospitalization for many patients with infectious diseases. The objective of this study was to describe the OPAT experience at a Canadian tertiary academic centre ...
Marie Yan   +3 more
doaj   +1 more source

Poster Sessions

open access: yes
HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Home_Visit_Observation_Template_Appendix – Supplemental material for It’s Complicated: Patient and Informal Caregiver Performance of Outpatient Parenteral Antimicrobial Therapy-Related Tasks

open access: yes, 2019
Supplemental material, Home_Visit_Observation_Template_Appendix for It’s Complicated: Patient and Informal Caregiver Performance of Outpatient Parenteral Antimicrobial Therapy-Related Tasks by Sara C. Keller, Sara E. Cosgrove, Alicia I. Arbaje, Rachel H.
Amanda Krosche (6802664)   +6 more
core   +1 more source

Publication Only

open access: yes
HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Exploring patients’ perspectives: a mixed methods study on Outpatient Parenteral Antimicrobial Therapy (OPAT) experiences

open access: yesBMC Health Services Research
Outpatient Parenteral Antimicrobial Therapy (OPAT), an alternative to inpatient intravenous antibiotic therapy, has shown benefits in international studies such as increased patient satisfaction. Because OPAT has been used only sporadically in Germany so
Sophie Peter   +11 more
semanticscholar   +1 more source

Outpatient parenteral antimicrobial therapy is safe and effective for the treatment of infective endocarditis : a retrospective cohort study

open access: yes, 2013
Outpatient parenteral antimicrobial therapy is safe and effective for the treatment of infective endocarditis : a retrospective cohort ...
A M Redden (13723006)   +6 more
core  

Outpatient parenteral antimicrobial therapy for orthopedic infections – a successful public healthcare experience in Brazil

open access: yes, 2016
Treatment of orthopedic infections usually requires prolonged antimicrobial therapy, ranging from 14 days up to 6 months. Nowadays, rising levels of antimicrobial resistance demands parenteral therapy for many patients.
Oliveira, Priscila Rosalba   +19 more
core   +1 more source

Dalbavancin as an alternative to traditional outpatient parenteral antimicrobial therapy for deep gram-positive infections – an observational, retrospective review

open access: yesTherapeutic Advances in Infectious Disease
Background: Treatment of invasive gram-positive infections in complex patient populations is challenging. Dalbavancin, approved for skin and soft tissue infections, offers advantages in this setting due to its long half-life and infrequent dosing ...
Hongkai Bao   +5 more
semanticscholar   +1 more source

Evaluation of health-related quality of life in patients receiving outpatient parenteral antimicrobial therapy (OPAT) in a UK setting

open access: yesExpert Review of Anti-Infective Therapy
Background Studies assessing the benefits of outpatient parenteral antimicrobial therapy (OPAT) have paid less attention to patient-centered factors such as patients’ experiences and their health-related quality of life (HRQoL).
O. Durojaiye, Evangelos I. Kritsotakis
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy